ArticleEMBO molecular medicine2026

Neoantigens and shared MICB α3 antigen dual-targeted vaccine generates potent antitumor immunity.

Ruijing Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.